[1]CurrentPatentAssignee:JFEHOLDINGSINC;SNTCORPORATION-US5650428,1997,A
[1]Akhtar,Arusa;Arshad,MuhammadNadeem;Asiri,AbdullahM.;Danish,Muhammad;Rani,Hurria;Raza,MuhammadAsam[JournalofMolecularStructure,2021,vol.1241]
90291-46-6
13505-32-3
40279-97-8
40279-96-7
42384-33-8
86117-53-5
31755-80-3 | 6-(4-Fluorophenyl)-2-oxo-1,2-dihydro-3-pyridinecarbonitrile | AA00C859 | MFCD00202736
37806-41-0 | 3-(SEC-BUTOXY)PHENYL]METHANAMINE | AA00C88U | MFCD09991465
366452-98-4 | 4-Aminoisoindolin-1-one | AA00C8CH | MFCD08234883
3650-93-9 | 4-Amino-2-hydroxypyrimidine-5-carboxylic acid hydrobromide | AA00C8GU | MFCD00047368
352340-66-0 | 1-(3,5-Dimethoxybenzoyl)piperidine-4-carboxylic acid | AA00C8LC | MFCD01241167
385383-41-5 | 3-(4-((2,4-Dichlorobenzyl)oxy)phenyl)acrylic acid | AA00C8PK | MFCD03001248
37014-08-7 | 1-(3-METHOXYPHENYL)-2-THIOUREA | AA00C8TT | MFCD00060446
34104-67-1 | HALOPERIDOL METABOLITE II | AA00C8XX | MFCD00055102
34604-55-2 | 3-hydroxylidocaine | AA00C942 | MFCD00869530
39998-64-6 | N-(2-(4-Hydroxy-5-methoxy-1H-indol-3-yl)ethyl)acetamide | AA00C9AT